Roosevelt Desronvilles | Regenerative Medicine | Best Researcher Award

Mr. Roosevelt Desronvilles | Regenerative Medicine | Best Researcher Award

Orthobiologics Research Initiative Inc., United States

Roosevelt Desronvilles is a dynamic and driven clinical research coordinator with a strong foundation in regenerative medicine. With a background in molecular and cellular biology, he has demonstrated leadership and innovation in clinical trials and research focused on orthobiologics and tissue regeneration. He is currently involved in groundbreaking research on micro-fragmented adipose tissue, platelet-rich plasma, and stem cell therapies for musculoskeletal and neurological conditions. Roosevelt’s extensive experience spans clinical research, data collection, grant writing, and manuscript submission. He has published in prominent journals and actively participates in conferences, advocating for novel regenerative treatments. His academic rigor, hands-on experience, and dedication to advancing medical science make him a distinguished contributor to his field.

Profile

Orcid

Education

Roosevelt Desronvilles earned his Bachelor of Science in Molecular and Cellular Biology from Johns Hopkins University in May 2021. His education provided a strong foundation in molecular biology, cell physiology, and experimental research techniques. At Johns Hopkins, Roosevelt engaged in cutting-edge laboratory research, developing the technical expertise and problem-solving skills necessary for success in clinical and translational science. His coursework and hands-on experiences at the university’s prestigious laboratories prepared him to approach complex biological questions with precision and a multidisciplinary perspective. Roosevelt’s academic achievements have enabled him to transition smoothly into professional roles within clinical research, where he continues to apply the knowledge and methodologies learned at Johns Hopkins to real-world challenges in regenerative medicine and clinical trials.

Experience

Roosevelt Desronvilles has extensive hands-on experience in clinical research and medical practices. He currently works as a Clinical Research Coordinator at Orthobiologics Research Initiative, where he co-designed and managed clinical trials, including a study on the effectiveness of micro-fragmented adipose tissue for rotator cuff tears. Roosevelt’s role includes grant writing, manuscript submission, and contributing to pivotal research on orthobiologics like bone marrow aspirate and platelet-rich plasma. He also works as a Medical Scribe/Research Assistant at Regenerative Orthopedics and Sports Medicine, performing diagnostic tasks and assisting in the preparation and administration of various biologic treatments. In the past, he was a Clinical Allergy Specialist at United Allergy Services, administering allergy tests and providing immunotherapy treatments. Roosevelt has presented his research at medical conferences and has been involved in multiple publications, underscoring his commitment to advancing the field.

Research Focus

Roosevelt Desronvilles’ research focuses on regenerative medicine, particularly the use of orthobiologics for musculoskeletal and neurological conditions. He is passionate about exploring the therapeutic potential of micro-fragmented adipose tissue, bone marrow aspirate, platelet-rich plasma, and stellate ganglion blocks. His research aims to improve the outcomes of clinical treatments for conditions such as rotator cuff tears, hip osteoarthritis, and post-traumatic stress disorder (PTSD). Roosevelt’s work in clinical trials and data collection is driven by the desire to improve patient care and explore alternative therapies for conditions that may benefit from regenerative approaches. His published studies and ongoing research highlight the effectiveness and long-term durability of these therapies, contributing valuable insights to the field of regenerative medicine.

Publication Top Notes

  1. Three-Month Durability of Bilateral Two-Level Stellate Ganglion Blocks in Patients with Generalized Anxiety Disorder: A Retrospective AnalysisBrain Sciences (2025)
  2. Long-Term Durability of Bilateral Two-Level Stellate Ganglion Blocks in Posttraumatic Stress Disorder: A Six-Month Retrospective AnalysisClinical and Translational Neuroscience (2025)
  3. Regeneration of Full-Thickness Common Extensor Tendon Tear After Percutaneous Microfragmented Adipose GraftRegenerative Medicine (2024)
  4. Treating External Anal Sphincter Injury with Platelet-Rich Plasma to Resolve Postpartum Fecal Incontinence Caused by Birthing Trauma: A Case ReportJournal of Case Reports and Images in Obstetrics and Gynecology (2025)

 

 

Ali Golchin | Cell-based therapy | Best Researcher Award

Assist Prof Dr Ali Golchin | Cell-based therapy | Best Researcher Award

Assistant professor, Urmia university of medical sciences, Iran

Ali Golchin is an accomplished researcher specializing in cell-based therapy and regenerative medicine. With an H-index of 18, he ranks among the top 2% of scientists globally, recognized by Elsevier and Stanford University from 2022 to 2024. Currently a faculty member at Urmia University of Medical Sciences, Golchin has made significant contributions to the fields of wound healing, tissue engineering, and the development of innovative cell delivery systems. He holds a Ph.D. in Applied Cell Sciences and is actively involved in various editorial boards and professional societies. Passionate about advancing cell therapy, he is dedicated to enhancing treatment strategies for skin, bone, and dental applications. His research continues to influence clinical practices and offers new avenues for regenerative medicine.

Profile

Strengths for the Award

  1. Research Impact:
    • An H-index of 18 (Scopus) demonstrates a significant number of citations for his research, indicating his work is widely recognized and has had a meaningful impact on the field.
    • Being ranked in the top 2% of scientists by Elsevier and Stanford University over the last three years highlights his stature in the scientific community.
  2. Expertise in Emerging Fields:
    • Specialization in cell-based therapy and regenerative medicine, with a focus on practical applications such as wound healing and tissue engineering.
    • Involvement in numerous academic projects, indicating a commitment to advancing knowledge and practical solutions in his field.
  3. Leadership and Editorial Roles:
    • Active member of the editorial board for reputable journals and involvement in scientific committees. This showcases his influence in guiding research trends and standards.
    • Board member roles in professional societies, demonstrating leadership in promoting the field of regenerative medicine.
  4. Extensive Publication Record:
    • Authored numerous influential papers, including several on current global health issues such as COVID-19. His publications cover a range of critical topics in regenerative medicine, indicating a versatile and impactful research portfolio.
  5. Ongoing Commitment to Education and Professional Development:
    • Pursuing further education (Master of Medical Education) shows a dedication to enhancing his skills and knowledge base, essential for a researcher aiming for continuous improvement.

Areas for Improvement

  1. Broader International Collaboration:
    • While his work is impactful, increasing collaborations with international researchers could enhance the global relevance and reach of his studies.
  2. Diversification of Research Areas:
    • Exploring additional interdisciplinary research areas could further broaden the impact of his work and introduce innovative perspectives into his studies.
  3. Public Engagement and Outreach:
    • Increasing efforts to engage with non-academic audiences through workshops or public talks could enhance the societal impact of his research, making it more accessible and applicable to broader issues.

Education 

Ali Golchin earned his Ph.D. in Applied Cell Sciences from Shahid Beheshti Medical University in Tehran, Iran, where he investigated the potency of Human Buccal Fat Pad Derived-Mesenchymal Stem Cells. His academic journey began with a Doctor of Veterinary Medicine (DVM) from the University of Tabriz, where he researched in-vitro fertilization techniques. Additionally, he holds a Master of Business Administration in Healthcare, and he is currently pursuing a Master of Medical Education at Shahid Beheshti Medical University. His strong educational background, coupled with extensive research training, has equipped him with the skills necessary to excel in the rapidly evolving fields of cell therapy and regenerative medicine.

Experience 

With extensive experience in cell-based therapy and regenerative medicine, Ali Golchin has successfully led numerous research projects and clinical trials. He has contributed to the development of advanced cell delivery systems and biomaterials for tissue engineering applications, focusing on wound healing and skin regeneration. Golchin has held leadership roles on the boards of multiple professional societies, including Iran’s Tissue Engineering and Regenerative Medicine Society, where he is a member of the board of directors. He serves on the editorial boards of several prestigious journals and has reviewed articles for various scientific publications. His role as a guest editor for Frontiers in Cell and Developmental Biology showcases his expertise and commitment to advancing the field. Golchin’s research has consistently focused on translating laboratory findings into clinical applications, ultimately improving patient outcomes in regenerative medicine.

Research Focus 

Ali Golchin’s research focuses on cell-based therapy, tissue engineering, and regenerative medicine. He is particularly interested in developing innovative strategies for wound healing and tissue regeneration across various applications, including bone, skin, and dental tissues. His work emphasizes the potential of mesenchymal stem cells and exosomes in therapeutic contexts, exploring their roles in enhancing healing processes and combating diseases. Golchin has led projects investigating the fabrication of nanofibrous scaffolds, the use of bioactive materials, and the molecular mechanisms underlying stem cell differentiation. He is also committed to studying the impact of inflammatory cytokines in conditions such as COVID-19. Through his research, Golchin aims to bridge the gap between laboratory science and clinical practice, ultimately contributing to more effective and personalized treatment options for patients.

Publication Top Notes

  • Mesenchymal stem cell therapy for COVID-19: present or future
  • Biological products: cellular therapy and FDA approved products
  • Potential therapeutic options for COVID-19: an update on current evidence
  • The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review
  • The Exosomes Released from Different Cell types and Their Effects in Wound Healing
  • Bone tissue engineering: Adult stem cells in combination with electrospun nanofibrous scaffolds
  • Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
  • Electrospun polycaprolactone nanofibers: current research and applications in biomedical application
  • Enzymatic antioxidant and lipid peroxidation evaluation in the newly diagnosed breast cancer patients in Iran
  • Biological behavior of the curcumin incorporated chitosan/poly (vinyl alcohol) nanofibers for biomedical applications

Conclusion

Ali Golchin is a highly qualified candidate for the Best Researcher Award, with a strong foundation in impactful research, leadership roles in the scientific community, and an ongoing commitment to education and professional development. His contributions to regenerative medicine and cell therapy are significant, and his recognition in top scientist rankings further supports his candidacy. With a focus on expanding international collaboration and public engagement, he could enhance his already impressive profile, positioning him even more favorably for such prestigious accolades.